Metoprolol Succinate Extended Release Tablets

Nazione: Nuova Zelanda

Lingua: inglese

Fonte: Medsafe (Medicines Safety Authority)

Principio attivo:

Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg

Commercializzato da:

AFT Pharmaceuticals Ltd

INN (Nome Internazionale):

Metoprolol succinate 23.75 mg (equivalent to metoprolol tartrate 25mg)

Dosaggio:

23.75 mg

Forma farmaceutica:

Modified release tablet

Composizione:

Active: Metoprolol succinate 23.75mg equivalent to metoprolol tartrate 25mg Excipient: Cellulose acetate Crospovidone Glyceryl monostearate Hypromellose Methacrylic acid copolymer Microcrystalline cellulose Opadry clear YS-1-7006 Opadry white YS-1-7003 Poloxamer 188 Polysorbate 80 Sugar spheres

Tipo di ricetta:

Prescription

Prodotto da:

Watson Pharma Private Limited

Indicazioni terapeutiche:

Metoprolol Succinate Extended-Release Tablets are indicated for the treatment of: Hypertension - to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions.

Dettagli prodotto:

Package - Contents - Shelf Life: Bottle, plastic, HDPE bottle with PP cap - 100 tablets - 36 months from date of manufacture stored at or below 25°C

Data dell'autorizzazione:

2016-06-24